Even With Support Letters, 50% Cuts Reality

Discussion in 'Precision Therapeutics' started by Anonymous, May 23, 2012 at 5:17 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Your high character leaders want to use you like drug mules, to carry and sell their "drug", the support letters to the gyn onc community.

    Drink a Red Bull and wake up! Even if gyn coverage is perserved, this is still only 45% of PTI's spec volume. No way does carrier continue to pay for non-gyn tumors when chances are high they may not cover ChemoFx gyn claims based on their draft comments.

    Half of you will be used and crapped out once the support letter campaign is complete.
     

  2. Anonymous

    Anonymous Guest

    Is this the crap upper management at this place is feeding to its employees now? Why would medicare continue to pay out on gyn claims when there isn't any data supporting this POS since 2007? Come on people, get real. The same thing happened with Oncotech in 2010 - they closed their doors within a month of getting denied. PTI will hold on a bit longer because they are slave drivers/delusional, but my bet is the production lab will be downsized dramatically, the sales team will remain fine and dandy for a little while, and the rest of the people in this company who are actually worth anything will be let go.

    Please everyone - be smart and get out before you don't have another option!!